BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26330465)

  • 21. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.
    Morelli V; Palmieri S; Salcuni AS; Eller-Vainicher C; Cairoli E; Zhukouskaya V; Scillitani A; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Feb; 168(2):235-41. PubMed ID: 23169694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients.
    Mitchell IC; Auchus RJ; Juneja K; Chang AY; Holt SA; Snyder WH; Nwariaku FE
    Surgery; 2007 Dec; 142(6):900-5; discussion 905.e1. PubMed ID: 18063074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma.
    Eller-Vainicher C; Morelli V; Salcuni AS; Battista C; Torlontano M; Coletti F; Iorio L; Cairoli E; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
    Eur J Endocrinol; 2010 Dec; 163(6):925-35. PubMed ID: 20881060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
    Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
    Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome.
    Tsurutani Y; Miyoshi K; Inoue K; Takiguchi T; Saito J; Omura M; Nishikawa T
    Endocr J; 2019 Mar; 66(3):207-214. PubMed ID: 30674738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.
    Prete A; Paragliola RM; Bottiglieri F; Rota CA; Pontecorvi A; Salvatori R; Corsello SM
    Endocrine; 2017 Mar; 55(3):969-980. PubMed ID: 27395418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study.
    Sereg M; Szappanos A; Toke J; Karlinger K; Feldman K; Kaszper E; Varga I; Gláz E; Rácz K; Tóth M
    Eur J Endocrinol; 2009 Apr; 160(4):647-55. PubMed ID: 19174533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Prophylactic Steroid Treatment Mandatory for Subclinical Cushing Syndrome After Unilateral Laparoscopic Adrenalectomy?
    Wang D; Li HZ; Zhang YS; Wang L; Ji ZG
    Surg Laparosc Endosc Percutan Tech; 2019 Feb; 29(1):31-35. PubMed ID: 30300254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism.
    Masserini B; Morelli V; Palmieri S; Eller-Vainicher C; Zhukouskaya V; Cairoli E; Orsi E; Beck-Peccoz P; Spada A; Chiodini I
    J Endocrinol Invest; 2015 Jun; 38(6):623-8. PubMed ID: 25608646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged Adrenal Suppression after Adrenalectomy for Subclinical Hypercortisolism.
    Shacham EC; Ishay A
    Isr Med Assoc J; 2015 Nov; 17(11):722-3. PubMed ID: 26757574
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.
    Petramala L; Cavallaro G; Galassi M; Marinelli C; Tonnarini G; Concistrè A; Costi U; Bufi M; Lucia P; De Vincentis G; Iannucci G; De Toma G; Letizia C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):69-75. PubMed ID: 28138953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism.
    Honda K; Sone M; Tamura N; Sonoyama T; Taura D; Kojima K; Fukuda Y; Tanaka S; Yasuno S; Fujii T; Kinoshita H; Ariyasu H; Kanamoto N; Miura M; Yasoda A; Arai H; Ueshima K; Nakao K
    J Hypertens; 2013 Oct; 31(10):2010-7. PubMed ID: 23846863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functioning adrenal adenoma and pheochromocytoma in the same adrenal gland: two discrete adrenal incidentalomas.
    Park GE; Cho YY; Hong YS; Kang SH; Lee KH; Lee HW; Kim JH
    Korean J Intern Med; 2015 Jan; 30(1):114-7. PubMed ID: 25589844
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy.
    Brauckhoff M; Gimm O; Thanh PN; Bär A; Ukkat J; Brauckhoff K; Bönsch T; Dralle H
    Surgery; 2003 Dec; 134(6):1020-7; discussion 1027-8. PubMed ID: 14668736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.
    Ortiz DI; Findling JW; Carroll TB; Javorsky BR; Carr AA; Evans DB; Yen TW; Wang TS
    Surgery; 2016 Jan; 159(1):259-65. PubMed ID: 26422766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Adrenal Venous Sampling in Patients with Bilateral Adrenal Masses and ACTH-Independent Cushing's Syndrome.
    Acharya R; Dhir M; Bandi R; Yip L; Challinor S
    World J Surg; 2019 Feb; 43(2):527-533. PubMed ID: 30232569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.